Hochschulschrift
In silico-Design, Synthese und Evaluation von Kinase- und Proteasom-Inhibitoren sowie Fluoreszenzsonden.
- Weitere Titel
-
In silico design, synthesis and evaluation of kinase and proteasome inhibitors as well as fluorescent probes.
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Deutsch
- Anmerkungen
-
Darmstadt, Technische Universität Darmstadt, Dissertation, 2015
- Klassifikation
-
Medizin, Gesundheit
Chemie
- Schlagwort
-
Proteasom
Inhibitor
Fluoreszenzsonde
Evaluation
Ubiquitin
Enzymsubstrat
Proteine
Chemische Synthese
Seitenkette
Struktur-Aktivitäts-Beziehung
Chymotrypsin
QSAR
- Ereignis
-
Veröffentlichung
- (wo)
-
Darmstadt
- (wer)
-
Universitäts- und Landesbibliothek Darmstadt
- (wann)
-
2015
- Urheber
- Beteiligte Personen und Organisationen
- URN
-
urn:nbn:de:tuda-tuprints-46185
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Scholz, Christoph
- Schmidt, Boris
- Kolmar, Harald
- Schirmeister, Tanja
- Universitäts- und Landesbibliothek Darmstadt
Entstanden
- 2015
Ähnliche Objekte (12)
Untersuchung von Peptidomimetika als Inhibitoren für das Chemokin CXCL8
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Synthesis and investigation of 2-substituted hetero-/arylacetic acids as bottom groups for selective inhibitors of the FK506-binding protein 51 (FKBP51)
In-silico-Design, Synthese und Evaluation von Kinase- und Proteasom-Inhibitoren sowie Fluoreszenzsonden
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Untersuchung von Peptidomimetika als Inhibitoren für das Chemokin CXCL8
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Synthesis and investigation of 2-substituted hetero-/arylacetic acids as bottom groups for selective inhibitors of the FK506-binding protein 51 (FKBP51)
In-silico-Design, Synthese und Evaluation von Kinase- und Proteasom-Inhibitoren sowie Fluoreszenzsonden
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells
Hybrid Multimeric Architectures for Enhanced Receptor Targeting and Intracellular Delivery of Bioactive Cargoes
Untersuchung von Peptidomimetika als Inhibitoren für das Chemokin CXCL8
Elucidation of the molecular and cellular mechanisms of FKBP51-selective inhibitors
Targeted Combination Therapy: Discovery and Evaluation of Synergistic Anticancer Effects of Anti-HER2-Duocarmycin Antibody-Drug Conjugates Combined with ATR Inhibitors
Synthesis and investigation of 2-substituted hetero-/arylacetic acids as bottom groups for selective inhibitors of the FK506-binding protein 51 (FKBP51)
In-silico-Design, Synthese und Evaluation von Kinase- und Proteasom-Inhibitoren sowie Fluoreszenzsonden
Charakterisierung von Zellwandproteinen des Transglutaminase-Produzenten Streptomyces mobaraensis
Antibody-mediated inhibition of MHC class I chain-related protein A shedding for tumor therapy
Flavors of biotin ligases: From research tools towards biopharmaceutical applications
Arming Antibodies for Cancer Therapy: Transglutaminase-Mediated Toxin Conjugation
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Evaluation of Yeast Display Fab Libraries Derived from Tumor Infiltrating B Cells